Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2

Arif O. Khan, Mohammed Almutlaq, Darren T. Oystreck, Elizabeth C. Engle, Khaled Abu-Amero, Thomas Bosley

Research output: Contribution to journalArticle

Abstract

Introduction: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a distinct non-syndromic form of congenital incomitant strabismus secondary to orbital dysinnervation from recessive mutations in the gene PHOX2A. The phenotype includes bilateral ptosis, very large angle exotropia, ophthalmoplegia, and poorly-reactive pupils. Other than amblyopia, afferent visual dysfunction has not been considered part of CFEOM2; however, we have repeatedly observed non-amblyopic subnormal vision in affected patients. The purpose of this study was to document this recurrent feature of the phenotype.Methods: A retrospective case series (2002-2012).Results: Eighteen patients (four families) were identified; all affected individuals had confirmed homozygous recessive PHOX2A mutations except one individual for whom genetic testing was not done because of multiple genetically confirmed family members. Age at assessment ranged from 5-62 years old (median 10 years old). All patients had decreased best-corrected visual acuity not completely explainable by amblyopia in both the preferred and non-preferred eye. In those patients who had further ancillary testing, visual fields (five patients) and electroretinography (10 patients) confirmed abnormalities not ascribable to amblyopia.Conclusions: In addition to a distinct form of congenital incomitant strabismus, the phenotype of CFEOM2 includes subnormal vision consistent with retinal dysfunction. This could be the direct result of PHOX2A mutations or a secondary effect of orbital dysinnervation.

Original languageEnglish (US)
Pages (from-to)130-136
Number of pages7
JournalOphthalmic Genetics
Volume37
Issue number2
DOIs
StatePublished - Apr 2 2016
Externally publishedYes

Fingerprint

Amblyopia
Low Vision
Strabismus
Phenotype
Mutation
Exotropia
Electroretinography
Ophthalmoplegia
Genetic Testing
Pupil
Visual Fields
Visual Acuity
Fibrosis of Extraocular Muscles, Congenital, 2
Genes

Keywords

  • Congenital cranial dysinnervation disorder
  • congenital fibrosis of the extraocular muscles
  • PHOX2A
  • retina

ASJC Scopus subject areas

  • Ophthalmology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)

Cite this

Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2. / Khan, Arif O.; Almutlaq, Mohammed; Oystreck, Darren T.; Engle, Elizabeth C.; Abu-Amero, Khaled; Bosley, Thomas.

In: Ophthalmic Genetics, Vol. 37, No. 2, 02.04.2016, p. 130-136.

Research output: Contribution to journalArticle

Khan, Arif O. ; Almutlaq, Mohammed ; Oystreck, Darren T. ; Engle, Elizabeth C. ; Abu-Amero, Khaled ; Bosley, Thomas. / Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2. In: Ophthalmic Genetics. 2016 ; Vol. 37, No. 2. pp. 130-136.
@article{f79c1b47633a478aa68b455c3b40cad5,
title = "Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2",
abstract = "Introduction: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a distinct non-syndromic form of congenital incomitant strabismus secondary to orbital dysinnervation from recessive mutations in the gene PHOX2A. The phenotype includes bilateral ptosis, very large angle exotropia, ophthalmoplegia, and poorly-reactive pupils. Other than amblyopia, afferent visual dysfunction has not been considered part of CFEOM2; however, we have repeatedly observed non-amblyopic subnormal vision in affected patients. The purpose of this study was to document this recurrent feature of the phenotype.Methods: A retrospective case series (2002-2012).Results: Eighteen patients (four families) were identified; all affected individuals had confirmed homozygous recessive PHOX2A mutations except one individual for whom genetic testing was not done because of multiple genetically confirmed family members. Age at assessment ranged from 5-62 years old (median 10 years old). All patients had decreased best-corrected visual acuity not completely explainable by amblyopia in both the preferred and non-preferred eye. In those patients who had further ancillary testing, visual fields (five patients) and electroretinography (10 patients) confirmed abnormalities not ascribable to amblyopia.Conclusions: In addition to a distinct form of congenital incomitant strabismus, the phenotype of CFEOM2 includes subnormal vision consistent with retinal dysfunction. This could be the direct result of PHOX2A mutations or a secondary effect of orbital dysinnervation.",
keywords = "Congenital cranial dysinnervation disorder, congenital fibrosis of the extraocular muscles, PHOX2A, retina",
author = "Khan, {Arif O.} and Mohammed Almutlaq and Oystreck, {Darren T.} and Engle, {Elizabeth C.} and Khaled Abu-Amero and Thomas Bosley",
year = "2016",
month = "4",
day = "2",
doi = "10.3109/13816810.2014.926942",
language = "English (US)",
volume = "37",
pages = "130--136",
journal = "Ophthalmic Genetics",
issn = "1381-6810",
publisher = "Aeolus Press",
number = "2",

}

TY - JOUR

T1 - Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2

AU - Khan, Arif O.

AU - Almutlaq, Mohammed

AU - Oystreck, Darren T.

AU - Engle, Elizabeth C.

AU - Abu-Amero, Khaled

AU - Bosley, Thomas

PY - 2016/4/2

Y1 - 2016/4/2

N2 - Introduction: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a distinct non-syndromic form of congenital incomitant strabismus secondary to orbital dysinnervation from recessive mutations in the gene PHOX2A. The phenotype includes bilateral ptosis, very large angle exotropia, ophthalmoplegia, and poorly-reactive pupils. Other than amblyopia, afferent visual dysfunction has not been considered part of CFEOM2; however, we have repeatedly observed non-amblyopic subnormal vision in affected patients. The purpose of this study was to document this recurrent feature of the phenotype.Methods: A retrospective case series (2002-2012).Results: Eighteen patients (four families) were identified; all affected individuals had confirmed homozygous recessive PHOX2A mutations except one individual for whom genetic testing was not done because of multiple genetically confirmed family members. Age at assessment ranged from 5-62 years old (median 10 years old). All patients had decreased best-corrected visual acuity not completely explainable by amblyopia in both the preferred and non-preferred eye. In those patients who had further ancillary testing, visual fields (five patients) and electroretinography (10 patients) confirmed abnormalities not ascribable to amblyopia.Conclusions: In addition to a distinct form of congenital incomitant strabismus, the phenotype of CFEOM2 includes subnormal vision consistent with retinal dysfunction. This could be the direct result of PHOX2A mutations or a secondary effect of orbital dysinnervation.

AB - Introduction: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a distinct non-syndromic form of congenital incomitant strabismus secondary to orbital dysinnervation from recessive mutations in the gene PHOX2A. The phenotype includes bilateral ptosis, very large angle exotropia, ophthalmoplegia, and poorly-reactive pupils. Other than amblyopia, afferent visual dysfunction has not been considered part of CFEOM2; however, we have repeatedly observed non-amblyopic subnormal vision in affected patients. The purpose of this study was to document this recurrent feature of the phenotype.Methods: A retrospective case series (2002-2012).Results: Eighteen patients (four families) were identified; all affected individuals had confirmed homozygous recessive PHOX2A mutations except one individual for whom genetic testing was not done because of multiple genetically confirmed family members. Age at assessment ranged from 5-62 years old (median 10 years old). All patients had decreased best-corrected visual acuity not completely explainable by amblyopia in both the preferred and non-preferred eye. In those patients who had further ancillary testing, visual fields (five patients) and electroretinography (10 patients) confirmed abnormalities not ascribable to amblyopia.Conclusions: In addition to a distinct form of congenital incomitant strabismus, the phenotype of CFEOM2 includes subnormal vision consistent with retinal dysfunction. This could be the direct result of PHOX2A mutations or a secondary effect of orbital dysinnervation.

KW - Congenital cranial dysinnervation disorder

KW - congenital fibrosis of the extraocular muscles

KW - PHOX2A

KW - retina

UR - http://www.scopus.com/inward/record.url?scp=84920823628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920823628&partnerID=8YFLogxK

U2 - 10.3109/13816810.2014.926942

DO - 10.3109/13816810.2014.926942

M3 - Article

VL - 37

SP - 130

EP - 136

JO - Ophthalmic Genetics

JF - Ophthalmic Genetics

SN - 1381-6810

IS - 2

ER -